Clinical Trial Update: A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis [Phase 1]

View source ↗

Summary

This update describes a Phase 1 study evaluating allogeneic hematopoietic cell transplantation for primary progressive multiple sclerosis, with status not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Stanford University | Conditions: Primary Progressive Multiple Sclerosis, Multiple Sclerosis | Phase 1 | Status: NOT_YET_RECRUITING